Affordable Access

Assessment of the role of thrombin activatable fibrinolysis inhibitor in retinal vein occlusion.

Authors
Type
Published Article
Journal
Retina (Philadelphia, Pa.)
Publication Date
Volume
27
Issue
5
Pages
578–583
Identifiers
PMID: 17558319
Source
Medline

Abstract

On the basis of these data, TAFI activity was not found to be a new risk factor for either type of RVO. However, further larger studies may better identify the exact role of TAFI in the pathogenesis of RVO.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments